Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rachel Jimenez, M.D.

Concepts (249)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms362023209882.040 Why?
Radiation Oncology1120235631.820 Why?
Radiotherapy, Intensity-Modulated320228011.450 Why?
Breast Implantation620222191.190 Why?
Mammaplasty5202212321.170 Why?
Radiotherapy Planning, Computer-Assisted12202216551.100 Why?
Breast Implants320224070.890 Why?
Radiotherapy Dosage11202228970.870 Why?
Radiotherapy, Conformal420225480.870 Why?
Mastectomy11202218170.800 Why?
Thoracic Wall320182020.660 Why?
Breast Neoplasms, Male120212120.650 Why?
Tattooing12019570.630 Why?
Sarcopenia120233700.610 Why?
Radiation Injuries3202211890.610 Why?
Mammary Neoplasms, Animal120181230.570 Why?
Curriculum9202237380.570 Why?
Medical Oncology4202223170.530 Why?
Mastectomy, Segmental320219550.530 Why?
Benchmarking1202210450.520 Why?
Organs at Risk420223590.510 Why?
Mediastinal Neoplasms120184010.500 Why?
Breast4202119630.460 Why?
Women's Health1202220650.410 Why?
Protons4202211120.410 Why?
Neuroectodermal Tumors, Primitive120131360.400 Why?
Pituitary Neoplasms1202113230.400 Why?
Neoplasms, Second Primary1202010510.400 Why?
Supratentorial Neoplasms120131590.400 Why?
Heart3202244030.390 Why?
Ventricular Dysfunction, Left1202221180.380 Why?
Radiobiology22020900.330 Why?
Lymphoma1201818990.310 Why?
Internship and Residency4202358780.310 Why?
Chemotherapy, Adjuvant4202335140.310 Why?
Cerebellar Neoplasms120135860.300 Why?
Medulloblastoma120136770.300 Why?
Lymph Nodes1201934610.300 Why?
Photons420195890.290 Why?
Female4420233921480.280 Why?
Humans6520237606170.270 Why?
Neoplasms62023221310.240 Why?
Clinical Clerkship320155640.230 Why?
Cultural Diversity220233690.220 Why?
Patient Participation1201314430.220 Why?
Neoplasm Recurrence, Local6202392770.220 Why?
Hypertension1202285290.200 Why?
Seroma12022730.200 Why?
Program Evaluation4202024860.200 Why?
Family Leave12021180.190 Why?
Supreme Court Decisions120221330.180 Why?
Education, Nursing12021800.180 Why?
Relative Biological Effectiveness220213110.180 Why?
Sick Leave120211050.180 Why?
Clinical Trials as Topic3202379950.170 Why?
Cranial Irradiation220133900.170 Why?
Accreditation120234730.170 Why?
Students, Medical4202119340.170 Why?
Thorax120225550.160 Why?
Physics12019910.160 Why?
Troponin120225020.160 Why?
Retrospective Studies132023805660.160 Why?
Rib Fractures120201280.160 Why?
Education, Medical, Graduate2202323710.150 Why?
Craniopharyngioma120212760.150 Why?
Canada2202221180.150 Why?
Necrosis1202216100.150 Why?
Nausea120216790.150 Why?
Lymphatic Metastasis2201829130.150 Why?
Safety1202211490.150 Why?
Vomiting120216510.140 Why?
Moyamoya Disease120212650.140 Why?
Hematoma120227620.140 Why?
Policy120215060.140 Why?
Radiation-Sensitizing Agents120193490.140 Why?
Radiation Tolerance120194780.130 Why?
Patient Care Planning120219050.130 Why?
Physician-Patient Relations3202132390.130 Why?
Congresses as Topic120208020.130 Why?
Treatment Outcome112023645680.130 Why?
Patient Positioning120183260.120 Why?
Aged1420231690420.120 Why?
Antineoplastic Agents, Hormonal1202315200.120 Why?
Tumor Burden1202118920.120 Why?
Asymptomatic Diseases120185870.120 Why?
Cisplatin1202116500.120 Why?
Postoperative Care2201814670.120 Why?
Postoperative Complications32022156120.110 Why?
Pulmonary Fibrosis120185050.110 Why?
Disease-Free Survival2202168070.110 Why?
Fatigue1202115500.110 Why?
Vision Disorders1202110880.110 Why?
Small Molecule Libraries120197330.110 Why?
Middle Aged1820232205840.110 Why?
Headache1202112550.100 Why?
Quality of Life52022133470.100 Why?
Propensity Score1202019110.100 Why?
Health Services Needs and Demand1202014000.100 Why?
Ventricular Function, Left2202238730.100 Why?
Needs Assessment1201811390.100 Why?
Acculturation120131780.100 Why?
Surgical Flaps1202016700.090 Why?
Terminal Care2201317550.090 Why?
Schizophrenia, Paranoid120111030.090 Why?
Stroke Volume2202254860.090 Why?
Adult1620232209690.090 Why?
Endocrine System Diseases120132490.090 Why?
Proto-Oncogene Proteins p21(ras)1201917450.090 Why?
Terminally Ill120132400.090 Why?
Sleep Initiation and Maintenance Disorders1202010800.090 Why?
Ambulatory Care1202127680.090 Why?
Attitude to Death120134000.090 Why?
Bone Density Conservation Agents120177940.090 Why?
Peptide Fragments1202251100.080 Why?
Echocardiography1202249870.080 Why?
Massachusetts2202188330.080 Why?
Pectoralis Muscles22020840.080 Why?
Feedback320217900.080 Why?
Prospective Studies62022543600.080 Why?
Radiotherapy, Adjuvant3202017840.080 Why?
Antineoplastic Combined Chemotherapy Protocols32020117360.080 Why?
United States72022722720.080 Why?
Interviews as Topic2201326970.080 Why?
Patient Preference220139250.080 Why?
Young Adult52023591790.080 Why?
Feasibility Studies1201952390.070 Why?
Receptor, erbB-21201825530.070 Why?
Career Choice120147560.070 Why?
Kaplan-Meier Estimate1201864740.070 Why?
Radiology1202121130.070 Why?
Hearing Loss, Sensorineural120137810.070 Why?
Follow-Up Studies42022390630.070 Why?
Genomics1202358220.070 Why?
Body Height1201315650.070 Why?
Hospice Care120136770.070 Why?
Education, Medical, Undergraduate1201510680.070 Why?
Cultural Competency120092990.070 Why?
Survival Rate22018127190.070 Why?
Infant22021361520.060 Why?
Bone Neoplasms1201725270.060 Why?
Cross-Sectional Studies22023260490.060 Why?
Radiosurgery1201413390.060 Why?
Neoplasm Staging42021111160.060 Why?
Child, Preschool22021421880.060 Why?
Mass Screening1202054240.060 Why?
Male1120233603580.060 Why?
Neoadjuvant Therapy3202028270.050 Why?
Cause of Death1201336830.050 Why?
Coronavirus Infections1202030880.050 Why?
Lung2201899980.050 Why?
Pneumonia, Viral1202032090.050 Why?
Brain Neoplasms2201490260.050 Why?
Aged, 80 and over42023588940.050 Why?
Consensus2202131170.040 Why?
Linear Energy Transfer120211510.040 Why?
Governing Board12019500.040 Why?
Maximum Tolerated Dose120218830.040 Why?
Program Development2201512930.040 Why?
Administrative Personnel120191830.040 Why?
Logistic Models12013132450.040 Why?
Pandemics3202286450.040 Why?
Surgical Mesh120203110.030 Why?
Radiology, Interventional120214760.030 Why?
Costs and Cost Analysis1202216630.030 Why?
Longitudinal Studies12013145910.030 Why?
Cost Allocation12016490.030 Why?
Drug Screening Assays, Antitumor120197170.030 Why?
Lung Neoplasms22019133820.030 Why?
Certification120194180.030 Why?
Single-Blind Method1202015750.030 Why?
Cost-Benefit Analysis2202154910.030 Why?
Educational Measurement2201512520.030 Why?
Fluorouracil1202016420.030 Why?
Phenylurea Compounds120195290.030 Why?
Models, Econometric120162150.030 Why?
Gene Expression Regulation, Leukemic120196510.030 Why?
Organ Specificity1202019640.030 Why?
Device Removal120206290.030 Why?
Prognosis32023296000.030 Why?
Monte Carlo Method1202012570.030 Why?
DNA Breaks, Double-Stranded120196120.030 Why?
Clinical Trials, Phase III as Topic120178570.030 Why?
Chicago120142540.030 Why?
Carcinoma, Intraductal, Noninfiltrating120209260.030 Why?
Pyrazines1201912020.030 Why?
Diphosphonates120176350.030 Why?
Child12021800790.030 Why?
Adolescent12021882340.030 Why?
Markov Chains120169650.030 Why?
Advance Directives120132490.020 Why?
Randomized Controlled Trials as Topic22019101990.020 Why?
Imidazoles1201711750.020 Why?
Fear1202014770.020 Why?
Catheterization1201614280.020 Why?
Clinical Competence2201847890.020 Why?
Social Support1202021740.020 Why?
Tomography, X-Ray Computed32018205560.020 Why?
Age Factors22017183810.020 Why?
Retreatment120115960.020 Why?
Reoperation1202043000.020 Why?
Disease Management1202025060.020 Why?
Quality-Adjusted Life Years1201617220.020 Why?
Life Expectancy1201612390.020 Why?
Delusions120112980.020 Why?
Combined Modality Therapy1202185160.020 Why?
Hospitals, Teaching1201411550.020 Why?
Cell Survival1201957800.020 Why?
Proportional Hazards Models12023124470.020 Why?
Patient Selection1202042370.020 Why?
Communication1202238490.020 Why?
Radiometry120138120.020 Why?
Societies, Medical1201939000.020 Why?
Biopsy1201967620.020 Why?
Hospitals, General120117980.020 Why?
Multivariate Analysis12020120430.020 Why?
Decision Support Systems, Clinical1201611670.020 Why?
Small Cell Lung Carcinoma120114230.020 Why?
Animals120181682010.020 Why?
Faculty120093830.020 Why?
Steroids120119290.020 Why?
Problem-Based Learning120093560.020 Why?
Internet1201830900.020 Why?
Health Care Surveys1201324230.020 Why?
Risk Factors32020741150.020 Why?
Remission Induction1201123910.020 Why?
Recurrence1201784260.020 Why?
Academic Medical Centers1201527560.020 Why?
Heart Ventricles1201737960.020 Why?
Survival Analysis12017100730.010 Why?
HIV Infections12011173370.010 Why?
Pilot Projects1201886180.010 Why?
Dexamethasone1201119470.010 Why?
Mutation22019300160.010 Why?
Time Factors22018399130.010 Why?
Cell Proliferation12019104320.010 Why?
Adaptation, Psychological1201326290.010 Why?
Cell Line, Tumor12019169670.010 Why?
Coronary Disease1201659120.010 Why?
Registries1201782070.010 Why?
Boston1201493130.010 Why?
Caregivers1201322410.010 Why?
Sensitivity and Specificity12016146480.010 Why?
Radiography1201169610.010 Why?
Palliative Care1201135920.010 Why?
Reproducibility of Results12013200740.010 Why?
Disease Progression12011134950.010 Why?
Carcinoma, Non-Small-Cell Lung1201153190.010 Why?
Colorectal Neoplasms1201169250.010 Why?
Magnetic Resonance Imaging12014364020.000 Why?
Jimenez's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (249)
Explore
_
Co-Authors (97)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.